Quantority
CFX logo

Conflux CFX · perps

$0.0428

Price · 1h

CFX across exchanges

ExchangeFunding APROpen interestOI share
BBinance logoBinance+3.76%$3.12M43%
OOKX logoOKX+10.95%$1.62M22%
BBybit logoBybit+10.95%$1.40M19%
BBitget logoBitget+10.95%$1.13M16%

Funding annualized per venue interval; open interest is the latest reading per exchange.

Interpretation

CFX perpetual futures show modest activity with mixed directional signals. Open interest stands at $7.0M, having declined -6.4% over the past week despite a modest +2.4% rebound in the last 24 hours. The aggregated funding rate of 8.15% annualized is elevated enough to compensate long holders, yet the funding percentile of 45 places this squarely within CFX's recent historical range—neither stretched nor depressed relative to the last 90 days.

The leverage risk score of 6 indicates very low fragility in the current positioning structure. More notably, the liquidation imbalance of -1.00 shows a pronounced asymmetry: shorts experienced all measurable liquidations over the 24-hour window while longs remained untouched. This extreme short-side liquidation pressure, combined with a funding rate that still favors longs, suggests shorts have faced acute pain despite the modest overall market depth.

The week-long contraction in open interest against a positive funding rate implies deleveraging longs are exiting faster than new long positions have entered, even as the perpetual market maintains incentive for new longs. The 24-hour uptick in OI suggests some stabilization or fresh leverage entry, but the underlying trend remains downward and the absolute size of the market remains small relative to major assets.

About this analysis: written from the served metrics only and validated against the data — methodology · editorial policy. Not financial advice.Written 13 Jul, 06:00 · Data live to 13 Jul, 11:15 UTC
CFX FundingCFX Open InterestCFX LiquidationsCFX Risk
Disclosure: some exchange links are affiliate links — we may earn a commission at no cost to you. Data is for research only and is not financial advice.